Trials / Completed
CompletedNCT02158273
Medication Development in Alcoholism: Investigating PPAR Agonists
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- The Scripps Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugar Pill | 145 mg/day, oral pill, 9 days |
| DRUG | TRICOR (fenofibrate) | 145 mg/day, oral pill, 9 days |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2014-06-06
- Last updated
- 2017-06-02
- Results posted
- 2017-06-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02158273. Inclusion in this directory is not an endorsement.